Page last updated: 2024-10-23

bohemine and Cancer of Prostate

bohemine has been researched along with Cancer of Prostate in 1 studies

bohemine : Purine substituted on C-2, C-6 and N-9 with (3-hydroxypropyl)amino, benzylamino and isopropyl groups respectively; a synthetic, cell-permeable, cyclin-dependent kinase (CDK) inhibitor that is structurally similar to olomoucine and roscovitine.

Research Excerpts

ExcerptRelevanceReference
"Both olomoucine and bohemine were potent inhibitors of growth and viability; however, bohemine was two to three times more effective than olomoucine."1.31Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines. ( Hajdúch, M; Hlobilková, A; Kolár, Z; Lenobel, R; Lukesová, M; Mad'arová, J; Murray, PG; Perera, S; Strnad, M; Vojtesek, B, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mad'arová, J1
Lukesová, M1
Hlobilková, A1
Strnad, M1
Vojtesek, B1
Lenobel, R1
Hajdúch, M1
Murray, PG1
Perera, S1
Kolár, Z1

Other Studies

1 other study available for bohemine and Cancer of Prostate

ArticleYear
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
    Molecular pathology : MP, 2002, Volume: 55, Issue:4

    Topics: Cell Division; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Male; Neoplasm Proteins

2002